Aileron Therapeutics (ALRN) Institutional Ownership → Hurry! Buy this stock before the Robinhood traders do! (From Traders Agency) (Ad) Free ALRN Stock Alerts $3.23 +0.05 (+1.57%) (As of 06/11/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Aileron Therapeutics (NASDAQ:ALRN)CurrentInstitutional OwnershipPercentage90.89%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$167.57KNumber ofInstitutional Sellers(last 12 months)0 Get ALRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Aileron Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALRN Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Aileron Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/13/2024 Texas Capital Bank Wealth Management Services Inc26,171$174K0.0%+65.9%0.155% 2/8/2024 Texas Capital Bank Wealth Management Services Inc15,773$48K0.0%N/A0.323% 2/1/2024 Sigma Planning Corp16,580$51K0.0%N/A0.339% 2/15/2023 Alerce Investment Management L.P.830,466$1.97M2.3%-95.0%18.288% 2/10/2023 Blair William & Co. IL67,867$161K0.0%-94.5%1.495% 1/31/2023KCK LTD.22,341$53K0.1%-95.0%0.492% Get the Latest News and Ratings for ALRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aileron Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2022KCK LTD.446,817$101K0.2%-30.9%0.492% 4/25/2022 Bailard Inc.128,010$66K0.0%N/A0.141% 2/14/2022 Blair William & Co. IL1,067,489$601K0.0%+32.9%1.179% 2/11/2022KCK LTD.646,817$362K0.3%N/A0.714% 2/10/2022 Acadian Asset Management LLC85,274$47K0.0%N/A0.094% 2/4/2022 Envestnet Asset Management Inc.136,760$77K0.0%+152.4%0.151% 2/2/2022PVG Asset Management Corp50,300$28K0.1%+113.5%0.056% 1/27/2022Morgan Jess S & Co. Inc.100,000$56K0.0%+33.3%0.110% 11/16/2021 Keebeck Wealth Management LLC76,000$78K0.0%-51.2%0.084% 11/12/2021 Renaissance Technologies LLC734,721$749K0.0%-28.7%0.811% 11/9/2021Morgan Jess S & Co. Inc.75,000$76K0.1%N/A0.083% 11/9/2021 Barclays PLC25,279$26K0.0%+235.4%0.028% 11/9/2021 JFS Wealth Advisors LLC31,807$32K0.0%N/A0.035% 10/26/2021 Game Plan Financial Advisors LLC127,000$130K0.1%+27.0%0.140% 8/17/2021 Boothbay Fund Management LLC393,015$491K0.0%+11.8%0.434% 8/16/2021 State Street Corp71,200$89K0.0%N/A0.079% 8/13/2021 Renaissance Technologies LLC1,031,128$1.29M0.0%-17.5%1.142% 8/13/2021 Geode Capital Management LLC766,813$958K0.0%+34.1%0.849% 8/13/2021 Vanguard Group Inc.3,440,633$4.30M0.0%-5.9%3.809% 8/12/2021 Blair William & Co. IL688,044$860K0.0%+99.1%0.762% 8/4/2021 Envestnet Asset Management Inc.34,654$43K0.0%+45.1%0.038% 5/21/2021 Citadel Advisors LLC46,830$67K0.0%N/A0.052% 5/19/2021 Virtu Financial LLC146,341$209K0.0%+746.6%0.162% 5/18/2021 BVF Inc. IL5,265,555$7.53M0.3%N/A5.829% 5/18/2021 Citadel Advisors LLC46,830$67K0.0%N/A0.052% 5/17/2021 Ikarian Capital LLC2,800,000$4.00M0.1%N/A3.100% 5/13/2021 Renaissance Technologies LLC1,250,500$1.79M0.0%+97.1%1.385% 5/13/2021 Blair William & Co. IL345,594$494K0.0%+29.0%0.383% 5/12/2021 Northern Trust Corp127,883$183K0.0%+378.0%0.142% 5/12/2021 Geode Capital Management LLC571,738$817K0.0%+149.3%0.633% 5/12/2021 Satter Management CO. L.P.16,609,449$23.75M10.5%+118.3%18.394% 5/11/2021 Acadian Asset Management LLC134,419$192K0.0%+30.8%0.149% 5/5/2021Wade G W & Inc.100,993$144K0.0%N/A0.112% 5/4/2021 Envestnet Asset Management Inc.23,886$34K0.0%+105.2%0.026% [URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond4/28/2021 Game Plan Financial Advisors LLC77,500$112K0.1%+13.1%0.086% 2/11/2021 Satter Management CO. L.P.7,609,449$7.91M3.1%N/A9.101% 2/10/2021 Renaissance Technologies LLC634,381$660K0.0%-47.3%0.759% 2/9/2021 Blair William & Co. IL267,994$279K0.0%+10.8%0.321% 2/4/2021 GSA Capital Partners LLP86,562$90K0.0%N/A0.198% 1/20/2021 Kestra Advisory Services LLC30,000$33K0.0%N/A0.068% 1/19/2021 Game Plan Financial Advisors LLC68,500$71K0.1%N/A0.156% 11/9/2020 Acadian Asset Management LLC40,704$53K0.0%N/A0.102% 10/20/2020 Wedbush Securities Inc.35,000$45K0.0%N/A0.088% 8/12/2020 Goldman Sachs Group Inc.24,971$29K0.0%N/A0.064% 8/12/2020 Blair William & Co. IL238,544$281K0.0%-21.5%0.608% 8/7/2020 Virtu Financial LLC23,309$28K0.0%N/A0.061% 8/3/2020 Personal CFO Solutions LLC47,388$56K0.0%+106.0%0.124% 5/11/2020 Blair William & Co. IL303,944$101K0.0%-12.7%1.072% (Data available from 1/1/2016 forward) ALRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALRN shares? During the previous two years, the following institutional investors and hedge funds held shares of Aileron Therapeutics shares: Alerce Investment Management L.P. ($1.97M), Texas Capital Bank Wealth Management Services Inc ($174K), Blair William & Co. IL ($161K), and KCK LTD. ($53K), Sigma Planning Corp ($51K).Learn more on ALRN's institutional investors. What percentage of Aileron Therapeutics stock is owned by institutional investors? 90.89% of Aileron Therapeutics stock is owned by institutional investors. Learn more on ALRN's institutional investor holdings. Which institutional investors have been buying Aileron Therapeutics stock? The following institutional investors have purchased Aileron Therapeutics stock in the last 24 months: Texas Capital Bank Wealth Management Services Inc ($26.17K), and Sigma Planning Corp ($16.58K). How much institutional buying is happening at Aileron Therapeutics? Institutional investors have bought a total of 42,751 shares in the last 24 months. This purchase volume represents approximately $167.57K in transactions. Which Aileron Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Aileron Therapeutics stock in the last 24 months: Alerce Investment Management L.P. ($15.78M), Blair William & Co. IL ($1.16M), and KCK LTD. ($624.48K). How much institutional selling is happening at Aileron Therapeutics? Institutional investors have sold a total of 17,562,384 shares in the last 24 months. This volume of shares sold represents approximately $41.98M in transactions. Related Companies: PDS Biotechnology Major Shareholders Unity Biotechnology Major Shareholders Cumberland Pharmaceuticals Major Shareholders Vaccinex Major Shareholders Mersana Therapeutics Major Shareholders Aquestive Therapeutics Major Shareholders uniQure Major Shareholders Immutep Major Shareholders Enanta Pharmaceuticals Major Shareholders Atai Life Sciences Major Shareholders This page (NASDAQ:ALRN) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aileron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aileron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.